In this interview from the Video Journal of Biomedicine, Hannah Brown (Ipsos Healthcare, London, UK) discusses physician and patient treatment decision-making for relapsing–remitting multiple sclerosis.
Browsing: Neurodegenerative Disease Management
What is the optimal treatment for Duchenne muscular dystrophy in the MENA region? Find out in this paper published by Neurodegenerative Disease Management.
Here we review your favorite and most-read pieces from all five of our partnered journals in 2018, giving you access to the most popular articles over the last year.
Editor’s summary considering the effectiveness and tolerability of octagam in patients with chronic inflammatory demyelinating polyneuropathy.
A study from Neurodegenerative Disease Management explores the lack of understanding around juvenile Huntington’s disease and its symptoms.
Although exercise training has been advocated as a nonpharmacological treatment for multiple sclerosis-related fatigue, no consensus exists regarding its effectiveness.
Difficulty in turning in bed is rated as the most troublesome night-time symptom among Parkinson’s patients – this study aims to develop a practival objective method for home assessment of a patient’s ability to turn in bed.
This Review from Neurodegenerative Disease Management explores light therapy for Alzheimer’s disease and related dementias, and how to maximize treatment impact.
Jutley et al. discuss established glaucoma treatments, review promising new neuroprotective agents, and explore potential future treatments targeting the neurodenegerative processes in glaucoma.